Follow live updates and news coverage of the Senate confirmation hearing for RFK Jr. Stay up to date with real-time developments on key moments and outcomes for Trump’s nominee for health secretary.

As Louisiana schools remain stuck in the middle ... a panel of three judges heard arguments over the controversial mandate on Thursday morning. The law, which has been touted by Republicans ...

Rapid fat loss from GLP-1 medications like Ozempic can lead to 'Ozempic face ... contains proteins and lipids that form a protective barrier, preventing excessive water loss.

Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, said on Wednesday its net profit jumped 21 per cent in 2024 to 100 billion Danish ...

The CMS listed Ozempic, Rybelsus and Wegovy — all forms of semaglutide — at the top of the list of drugs for which Medicare will the negotiate the price of in 2025. The list price for a one ...

Novo Nordisk boasts 45 million customers using their drug Ozempic, which has caused a revolution in weight-loss treatment. Never before was there a drug that actually worked for weight loss.

Some people who use semaglutide (Ozempic, others) have noted sagging skin in the buttocks, calling it “Ozempic butt.” While lifestyle modifications may help prevent this weight loss side ...

Research shows that GLP-1 receptor agonists like Ozempic can help you drop weight, manage diabetes, and even potentially lower the risk of opioid overdoses. But now, a new study finds that taking ...

You may take Ozempic or another drug to control your diabetes ... associated with a decreased risk of Alzheimer’s and other forms of dementia. These diabetes and weight loss drugs work by ...

and Rybelsus (a tablet form of semaglutide FDA-approved to help type 2 diabetics manage their blood sugar). How does Ozempic work? Well, semaglutide is a glucagon-like peptide 1 (GLP-1 ...

A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite earlier hopes, a rigorous 96-week trial with 194 participants found no ...